Cargando…

Checkpoint Markers and Tumor Microenvironment: What Do We Know?

Detalles Bibliográficos
Autores principales:	Ephraim, Ramya, Fraser, Sarah, Nurgali, Kulmira, Apostolopoulos, Vasso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367329/ https://www.ncbi.nlm.nih.gov/pubmed/35954452 http://dx.doi.org/10.3390/cancers14153788

Ejemplares similares

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
por: Ephraim, Ramya, et al.
Publicado: (2022)

Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis
por: Ephraim, Ramya, et al.
Publicado: (2023)

The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
por: Barriga, Vanessa, et al.
Publicado: (2019)

Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines
por: Kuol, Nyanbol, et al.
Publicado: (2023)

Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer
por: Kuol, Nyanbol, et al.
Publicado: (2022)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients
por: Kuol, Nyanbol, et al.
Publicado: (2022)

Leucocyte-Rich Platelet-Rich Plasma Enhances Fibroblast and Extracellular Matrix Activity: Implications in Wound Healing
por: Devereaux, Jeannie, et al.
Publicado: (2020)

Role of the nervous system in cancer metastasis
por: Kuol, Nyanbol, et al.
Publicado: (2018)

Development and validation of a new method to isolate, expand, and differentiate circulating osteogenic precursor (COP) cells
por: Feehan, Jack, et al.
Publicado: (2021)

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
por: Davidson, Majid, et al.
Publicado: (2022)

Oxaliplatin Treatment Alters Systemic Immune Responses
por: Stojanovska, Vanesa, et al.
Publicado: (2019)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells
por: Mikkelsen, Kathleen, et al.
Publicado: (2019)

Circulating osteogenic precursor cells: Building bone from blood
por: Feehan, Jack, et al.
Publicado: (2018)

COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
por: Ikizler, T. Alp
Publicado: (2020)

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Publication ethics – What do we need to know?
por: Mills, Michael
Publicado: (2019)

Coffee and digestive cancers—what do we know, and where do we go?
por: Loftfield, Erikka, et al.
Publicado: (2020)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Ectopic Calcification: What Do We Know and What Is the Way Forward?
por: Snijders, Birgitta M. G., et al.
Publicado: (2023)

Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer
por: Khadela, Avinash, et al.
Publicado: (2023)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Tryptophan and Substance Abuse: Mechanisms and Impact
por: Davidson, Majid, et al.
Publicado: (2023)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

COVID-19 and Cardiovascular Surgery. Do We Know What We Are Dealing With?
por: Almeida, Rui M. S., et al.
Publicado: (2021)

COVID-19 virus and children: What do we know?
por: Morand, A., et al.
Publicado: (2020)

What Do We Know about Suicide Bereavement, and What We Can Do to Help Suicide-Loss Survivors?
por: Levi-Belz, Yossi, et al.
Publicado: (2023)

What we do and do not know about managing respiratory disease in pregnancy
por: Kent, Brian D.
Publicado: (2022)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
por: Craig, Colin F., et al.
Publicado: (2022)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Consistently doing what we know is right and important for “Medicine and Life”
por: Popa, F
Publicado: (2011)

Liver injury in COVID-19: What do we know now?
por: Yang, Hua-Yu, et al.
Publicado: (2020)

All eyes on Coronavirus—What do we need to know as ophthalmologists
por: Khanna, Rohit C, et al.
Publicado: (2020)

Posterior cruciate ligament injuries: what do we really know?
por: Winkler, Philipp W., et al.
Publicado: (2021)

COVID-19 and dizziness: What do we know so far?
por: Mezzalira, Raquel
Publicado: (2022)

Cancer Stem Cells: What Do We Know about Them?
por: Skvortsova, Ira
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_encf08niaf3i0dht9vk402602v